SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-054509
Filing Date
2012-08-06
Accepted
2012-08-06 13:26:35
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13652_110q.htm 10-Q 959640
2 EX-10.1 a12-13652_1ex10d1.htm EX-10.1 679948
3 EX-10.2 a12-13652_1ex10d2.htm EX-10.2 20089
4 EX-10.3 a12-13652_1ex10d3.htm EX-10.3 74553
5 EX-31.1 a12-13652_1ex31d1.htm EX-31.1 9638
6 EX-31.2 a12-13652_1ex31d2.htm EX-31.2 9706
7 EX-32.1 a12-13652_1ex32d1.htm EX-32.1 7205
  Complete submission text file 0001104659-12-054509.txt   9266775

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT isis-20120630.xml EX-101.INS 1046551
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20120630.xsd EX-101.SCH 117181
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20120630_cal.xml EX-101.CAL 36338
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20120630_lab.xml EX-101.LAB 1755620
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20120630_pre.xml EX-101.PRE 764168
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20120630_def.xml EX-101.DEF 510281
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 121009244
SIC: 2834 Pharmaceutical Preparations